University of Palermo   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Palermo Italy (1806)

Organization Overview

First Clinical Trial
1999
NCT00381511
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

A.O.U. Policlinico "Paolo Giaccone" | AOU Policlinico "P. Giaccone" - University of Palermo, Italy | AOUP Paolo Giaccone, Palermo | A.O.V. Cervello - Palermo | Aurelio Seidita | Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo | Casa di Cura La Maddalena - Palermo | Centro di Riferimento Regionale Malattie Extra Piramidali, Palermo | D. Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University | Faculty of Sport and Physical Education, University of Palermo | Hematology Unit- University of Palermo | Internal Medicine and Stroke Care Ward, University of Palermo, Italy | Internal Medicine, 'Giovanni Paolo II' Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy | Internal Medicine, Giovanni Paolo II Hospital of Sciacca (Agrigento) and University of Palermo, Palermo, Italy | Napolitano Mariasanta | Sezione di Gastroenterologia, Di.Bi.M.I.S. University of PALERMO, ITALY | Università degli Studi di Palermo | University Hospital of Palermo | University Hospital of Palermo, Italy | University Hospital of Palermo, Palermo, Italy | University of Palermo | University of Palermo - Italy | University of Palermo, Italy | UO Universita degi Studi Policinico Ematologia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

ACTH-Secreting Pituitary Adenoma (Phase 4)

Amyotrophic Lateral Sclerosis (Phase 2)

Ascites (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 2 (Phase 4)

Embolism (Phase 4)

Fatty Liver (Phase 4)

Fatty Liver, Alcoholic (Phase 3)

Fibrosis (Phase 2)

Heart Failure (Phase 4)

Hepatitis (Phase 3)

Hepatitis, Chronic (Phase 3)

Ischemia (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphoid (Phase 2)

Liver Diseases (Phase 3)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Motor Neuron Disease (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 4)

Parkinson Disease (Phase 3)

Pituitary ACTH Hypersecretion (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Pulmonary Embolism (Phase 4)

Sclerosis (Phase 2)

Stroke (Phase 4)

Thrombocytopenia (Phase 4)

Thrombosis (Phase 4)

Venous Thrombosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 42
  • # of Trial APIs: 46